Scribe Therapeutics SCTX 深 滬
等待開盤 10-07 09:30:00 美东时间
16.33
+0.120
+0.74%
華盛通- 最 高17.1699
- 今 開16.12
- 成交量 46.45万股
- 最 低 15.3701
- 昨 收 16.21
- 總市值 30.92万
- 52周最高 39.60
- 市盈率 靜 --
- 換手率 2453.41%
- 52周最低 13.50
- 委 比 -1.52%
- 總股本 1.89万
- 歷史最高 39.60
- 量 比 0.57
- 振 幅 11.10%
- 歷史最低 13.50
- 每 手 1
- 風險率 5.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Muse一夜爆红！“木头姐”大手笔增持Meta，加码医疗与生物科技
当地时间9月22日，“木头姐”Cathie Wood旗下方舟投资（ARK Invest）公布的每日交易纪录显示，持股重心明显偏向大型AI平台与基因精准医疗，同时...
09-23 09:49
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
Cathie Wood is doubling down on biotech, but investors looking beyond her ARK Genomic Revolution ETF (BATS:ARKG) have several other ways to gain exposure to the same companies. ARKG bought about $4.5 million of Ionis Pharmaceuticals Inc (NASDAQ:IONS), nearly $3 million of Veracyte Inc (NASDAQ:VCYT),...
09-22 22:40
Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF
Cathie Wood’s Ark Invest made several large portfolio moves last week, adding to CoreWeave (CRWV) while increasing exposure to healthcare and trimming positions across crypto, genomics and technology....
09-21 19:05
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI
Cathie Wood’s Ark Invest leaned further into high-growth themes, including space, fintech, crypto, and biotechnology, during the last week while trimming several large technology and healthcare positi...
09-07 19:10
美股大行评级 | 大行齐上调AI应用股目标价！Adobe、CRWD等获看好，慧与科技绩后现多空分歧
今日重点评级关注：BTIG：维持Climb Bio"买入"评级，目标价从20美元升至32美元；巴克莱：维持Alpha Tau Medical"超配"评级，目标价从17美元升至30美元
09-04 12:30
Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate
Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(2.62) per share which missed the analyst consensus estimate of $(1.05) by 149.52 percent. The company reported quarterly sales of $1.918 million which missed the analyst consensus estimate of $3.113 million by 38.39 percent.
09-03 04:10
Scribe Therapeutics to Participate in Upcoming Investor Conferences
Scribe Therapeutics announced that its management will participate in three upcoming investor conferences: the Wells Fargo Healthcare Conference on Sept. 9, 2026, where CEO Benjamin Oakes will engage in a fireside chat; the H.C. Wainwright Global Investment Conference on Sept. 15, 2026, with Oakes presenting; and the Cell & Gene Meeting on the Mesa on Oct. 5, 2026, where CFO David Parrot will deliver an Innovation Spotlight presentation. Scribe T...
09-01 12:00
美股大行评级 | Affirm、GitLab获多家大行上调目标价；Attovia获大摩、花旗首予买入评级
今日重点评级关注：杰富瑞：维持拜玛林制药"买入"评级，目标价从104美元升至105美元；RBC Capital：维持Shift4 Payments"跑赢大市"评级，目标价从63美元升至67美元
09-01 08:37
HC Wainwright & Co. Initiates Coverage On Scribe Therapeutics with Buy Rating, Announces Price Target of $60
HC Wainwright & Co. analyst Mitchell S. Kapoor initiates coverage on Scribe Therapeutics (NASDAQ:SCTX) with a Buy rating and announces Price Target of $60.
08-31 18:23
SpaceX continues to be Cathie's biggest bet; trims RBLX, PLTR, and AMD
Cathie Wood’s Ark Invest increased exposure to AI infrastructure, biotechnology, fintech, and space-related technologies during the August 17-21 trading week while making significant reductions in sof...
08-24 19:07
